Alterações

33- Liu MM, Tuo J, Chan C-C. Gene therapy for ocular diseases. Br J Ophthalmol. 2011;95(5):604-612.

3334- Ali RR, Sarra GM, Stephens C, et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25(3):306-310.

3435- Jomary C, Vincent KA, Grist J, et al. Rescue of photoreceptor function by AAV mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther. 1997;4(7):683-690.

3536- Sarra GM, Stephens C, De AM, et al. Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet. 2001;10(21):2353-2361.

3637- Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med. 2008;358(21):2231-2239.

3738- Hauswirth WW, Aleman TS, Kaushal S, et al. Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19(10):979-990.

3839- Maguire AM, Simonelli F, Pierce EA, et al. Safety and Efficacy of gene transfer for Leber congenital amaurosis. N Engl J Med. 2008;358(21):2240-2248

3940- Stieger K, Lorenz B. Gene therapy for vision loss -- recent developments. Discov Med. 2010;10(54):425-433.

4041- Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA. 2006;103(10):3896-3901.

4142- Talcott KE, Ratnam K, Sundquist SM, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52(5):2219-2226.

4243- Birch DG, Bennett LD, Duncan JL, Weleber RG, Pennesi ME. Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants. Am J Ophthalmol. 2016 Oct;170:10-14.

4344- Humayun MS, Weiland JD, Fujii GY, et al. Visual perception in a blind subject with a chronic microelectronic retinal prosthesis. Vision Res. 2003;43(24):2573-2581.

4445- Chow AY, Pardue MT, Perlman JI, et al. Subretinal implantation of semiconductor-based photodiodes: durability of novel implant designs. J Rehabil Res Dev 2002;39(3):313-321.

4546- Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, Juan ED; Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang S, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KD, Jayasundera KT. Worldwide Argus II Implantation: Recommendations to Optimize Patient Outcomes. BMC Ophthalmology 2016;16(1):52.

4647- da Cruz L, Coley BF, Dorn J, Merlini F, Filley E, Christopher P, Chen FK, Wuyyuru V, Sahel J, Stanga P, Humayun M, Greenberg RJ, Dagnelie G; Argus II Study Group. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol 2013 May;97(5):632-6.

4748- Luo YH, Zhong JJ, da Cruz L. The use of Argus® II retinal prosthesis by blind subjects to achieve localisation and prehension of objects in 3-dimensional space. Graefes Arch Clin Exp Ophthalmol. 2014 Dec 31. [Epub ahead of print].

4849- Stronks HC, Dagnelie G. The functional performance of the Argus II retinal prosthesis. Expert Rev Med Devices. 2014 Jan;11(1):23-30..

4950- Bastek JV, Heckenlively JR, Straatsma BR. Cataract surgery in retinitis pigmentosa patients. Ophthalmology 1982;89(8):880-884.

5051- Feskanich D, Singh V, Willett WC, Colditz GA: Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287(1):47-54.

5152- Michaelsson K, Lithell H, Vessby B, Melhus H: Serum retinol levels and the risk of fracture. N Engl J Med. 2003;348(4):287-294.

5253- deCruz et al. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis. Ophthalmology. 2016 Oct;123(10):2248-54.

5354- Ghodasra DH, et al. Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016 May 6;16:52. doi: 10.1186/s12886-016-0225-1.

5455- Fishman GA. Retinitis pigmentosa. Visual loss. Arch Ophthalmol. 1978;96(7):1185-1188.

5556- Fishman GA, Farber MD, Derlacki DJ. X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol. 1988;106(3):369-375.

5657- Lyness AL, Ernst W, Quinlan MP, et al. A clinical, psychophysical, and electroretinographic survey of patients with autosomal dominant retinitis pigmentosa. Br J Ophthalmol. 1985;69(5):326-339.

5758- Lang GE, Maumenee IH. Retinal dystrophies associated with storage disease. In: Newsome DA, ed. Retinal dystrophies and degenerations. New York, NY: Raven Press;1988:319-340.

5859- Newsome DA. Retinitis pigmentosa, Usher's syndrome, and other pigmentary retinopathies. In: Newsome DA, ed. Retinal dystrophies and degenerations. New York, NY: Raven Press; 1988:161-194.

5960- Heckenlively JR. Autosomal recessive retinitis pigmentosa: preserved para-arteriolar retinal pigment epithelial RP. In: Heckenlively JR, ed. Retinitis pigmentosa. Philadelphia, PA: JB Lippincott; 1988:151-154.

6061- Heckenlively JR. RP syndromes. In: Heckenlively JR, ed. Retinitis pigmentosa. Philadelphia, PA: JB Lippincott; 1988:221-252.

6162- Carr RE, Heckenlively JR. Hereditary pigmentary degenerations of the retina. In: Duane TD, Jaeger EA, eds. Clinical ophthalmology. Philadelphia, PA: JB Lippincott; 1987:1-28.

6263- Wright AF, Jay B, eds. Molecular genetics of inherited eye disorders. Switzerland: Harwood Academic Press;1994.